Aprepitant

CAS 170729-80-3 16 current recordsSmall Molecule

Who holds supplier records for Aprepitant? 16 organisations hold a current record for Aprepitant: an active US FDA Type II Drug Master File or a CEP. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (5), Spain (1), Italy (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Aprepitant: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/aprepitant

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Aprepitant expires 18 Sept 2035. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Aprepitant. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • MSN PHARMACHEM PRIVATE LTD
    Active DMF 29121, 24835, 27214 · latest filing Mar 2015
    IndiaCEP
  • Wisdom Pharmaceutical Co., Ltd
    Active DMF 38059, 33175, 44033 · latest filing Apr 2026
    ChinaCEP
  • ALIVUS LIFE SCIENCES LTD
    Active DMF 27610, 20381 · latest filing Jan 2014
    IndiaCEP Company GMP cert on record
  • Hetero Drugs Limited
    Active DMF 25572 · latest filing Dec 2011
    IndiaCEP Company GMP cert on record
  • INKE SA
    Active DMF 35497 · latest filing Apr 2022
    SpainCEP
  • JUBILANT BIOSYS LTD
    Active DMF 26852 · latest filing Mar 2013
    IndiaCEP
  • Piramal Pharma Limited
    Active DMF 26065 · latest filing May 2012
    IndiaCEP Company GMP cert on record
  • Shandong Anxin Pharmaceutical Co., Ltd.
    Active DMF 39641 · latest filing Mar 2024
    ChinaCEP Company GMP cert on record
  • SOLARA ACTIVE PHARMA SCIENCES LTD
    Active DMF 29215 · latest filing Mar 2015
    IndiaCEP Company GMP cert on record
  • Viwit Pharmaceutical Co., Ltd.
    Active DMF 33266, 25715, 28866 · latest filing Mar 2019
    ChinaCEP
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 21345 · latest filing Feb 2008
    India Company GMP cert on record
  • MAHI DRUGS PRIVATE LIMITED
    Active DMF 40624 · latest filing Oct 2024
    India
  • OLON SPA
    Active DMF 27784 · latest filing Dec 2013
    Italy Company GMP cert on record
  • Pharmathen S.A.
    Active DMF 32203 · latest filing Dec 2017
    Greece Company GMP cert on record
  • Sichuan Kelun Pharmaceutical Co., Ltd.
    Active DMF 39344 · latest filing Dec 2025
    China
  • Chengdu EASTON Biopharmaceuticals Co., Ltd.
    ChinaCEP
Need Aprepitant sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Aprepitant, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG ANXIN PHARMACEUTICAL CO., LTD JinanCN
CEP 2024-456 - Rev 01
Aprepitant, Form I, milled
Oct 2026Inspected Sept 2023
Austria, outside 3-year window
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2022-365 - Rev 02
Aprepitant
May 2026—
WISDOM PHARMACEUTICAL CO., LTD. HaimenCN
CEP 2019-117 - Rev 01
Aprepitant
Oct 2025—
JUBILANT BIOSYS LIMITED NanjangudIN
CEP 2017-051 - Rev 02
Aprepitant
Sept 2025—
HETERO DRUGS LIMITED HyderabadIN
CEP 2017-196 - Rev 03
Aprepitant
Mar 2025—
VIWIT PHARMACEUTICAL CO. LTD TengzhouCN
CEP 2019-025 - Rev 02
Aprepitant
Feb 2025—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2022-033 - Rev 00
Aprepitant, Form I
Jan 2025—
INKE, S.A. CastellbisbalES
CEP 2022-247 - Rev 00
Aprepitant, Micronised and non micronised
Oct 2024Inspected Mar 2023
Spain, outside 3-year window
PIRAMAL PHARMA LIMITED Digwal VillageIN
CEP 2017-192 - Rev 03
Aprepitant, Form-I
May 2024Inspected Jun 2025
Netherlands
CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. ChengduCN
CEP 2021-323 - Rev 00
Aprepitant
Jan 2024—
MSN PHARMACHEM PRIVATE LIMITED Sangareddy DistrictIN
CEP 2021-434 - Rev 01
Aprepitant, Route code AP
Oct 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (14 listed products contain Aprepitant). The latest listed patent expires 18 Sept 2035. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Aprepitant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1471).

Chemical identity

IUPAC name
5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
Canonical SMILES
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
InChIKey
ATALOFNDEOCMKK-OITMNORJSA-N
Synonyms
APONVIE, Aponvie, APREPITANT`, Aprepitant, APREPITANT, APREPITANT (MK-0869), CINVANTI, Cinvanti, EMEND, Emend, L-754,030, L-754030

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Substance P/Neurokinin-1 Receptor Antagonist
Mechanism of action
Cytochrome P450 2C9 Inducers; Cytochrome P450 3A4 Inducers; Cytochrome P450 3A4 Inhibitors; Neurokinin 1 Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Aprepitant?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Aprepitant: MSN PHARMACHEM PRIVATE LTD (India), Wisdom Pharmaceutical Co., Ltd (China), ALIVUS LIFE SCIENCES LTD (India), Hetero Drugs Limited (India), INKE SA (Spain), JUBILANT BIOSYS LTD (India), Piramal Pharma Limited (India) and Shandong Anxin Pharmaceutical Co., Ltd. (China), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Aprepitant Drug Master Files are active?

MSN PHARMACHEM PRIVATE LTD (DMF 29121, 24835), Wisdom Pharmaceutical Co., Ltd (DMF 38059, 33175), ALIVUS LIFE SCIENCES LTD (DMF 27610, 20381), Hetero Drugs Limited (DMF 25572), INKE SA (DMF 35497), JUBILANT BIOSYS LTD (DMF 26852), Piramal Pharma Limited (DMF 26065) and Shandong Anxin Pharmaceutical Co., Ltd. (DMF 39641) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Aprepitant have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Aprepitant on the EDQM register, including SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan (CN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), WISDOM PHARMACEUTICAL CO., LTD. Haimen (CN), JUBILANT BIOSYS LIMITED Nanjangud (IN), HETERO DRUGS LIMITED Hyderabad (IN) and VIWIT PHARMACEUTICAL CO. LTD Tengzhou (CN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Aprepitant?

Yes. The latest patent listed for an approved US product containing Aprepitant expires 18 Sept 2035, across 14 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Aprepitant supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Aprepitant?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.